Cargando…
Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma
BACKGROUND: Global deregulation of DNA methylation is one of the crucial causes of hepato cellular carcinoma (HCC). It has been reported that the anti-cancer drug 5-azacytidine (5-AZA) mediates the activation of tumor suppressor genes through passive demethylation by inhibiting DNMT1. Recent evidenc...
Autores principales: | Sajadian, Sahar Olsadat, Ehnert, Sabrina, Vakilian, Haghighat, Koutsouraki, Eirini, Damm, Georg, Seehofer, Daniel, Thasler, Wolfgang, Dooley, Steven, Baharvand, Hossein, Sipos, Bence, Nussler, Andreas K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567821/ https://www.ncbi.nlm.nih.gov/pubmed/26366235 http://dx.doi.org/10.1186/s13148-015-0133-x |
Ejemplares similares
-
Vitamin C enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7
por: Sajadian, Sahar Olsadat, et al.
Publicado: (2016) -
TET Enzymes and 5hmC in Adaptive and Innate Immune Systems
por: Lio, Chan-Wang J., et al.
Publicado: (2019) -
Global DNA 5hmC and CK19(5hmC+) Contents: A Promising Biomarker for Predicting Prognosis in Small Hepatocellular Carcinoma
por: Jiang, Jinhua, et al.
Publicado: (2021) -
Exploring role of 5hmC as potential marker of chemoresistance
por: Kharat, Suhas S., et al.
Publicado: (2020) -
Analysis of the machinery and intermediates of the 5hmC-mediated DNA demethylation pathway in aging on samples from the MARK-AGE Study
por: Valentini, Elisabetta, et al.
Publicado: (2016)